Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes

Journal of Immunology

Volumn 174, Issue 7, 2005, Pages 4295-4300

  Kalis, Christoph ^a   Gumenscheimer, Marina ^a   Freudenberg, Nikolaus ^a   Tchaptchet, Sandrine ^a   Fejer, György ^a   Heit, Antje ^c   Akira, Shizuo ^b   Galanos, Chris ^a   Freudenberg, Marina A ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b OSAKA UNIVERSITY   (Japan)

^c Institut Medizinische Mikrobiologie   (Germany)

^d MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; GAMMA INTERFERON; LIPID A; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; EXTRAMEDULLARY HEMATOPOIESIS; IMMUNOMODULATION; LIVER GRANULOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; SPLENOMEGALY; TYPHOID FEVER;

EID: 15444376617     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.7.4295     Document Type: Article

References (58)

1. Brook, I., and E. H. Frazier. 1991. Infections caused by Propionibacterium species. Rev. Infect. Dis. 13:819.
2. Jakab, E., R. Zbinden, J. Gubler, C. Ruef, A. von Graevenitz, and M. Krause. 1996. Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale J. Biol. Med. 69:477.
3. Fisher, B., N. Wolmark, E. Saffer, and E. R. Fisher. 1975. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors. Cancer 35:134.
4. Millman, I., A. W. Scott, and T. Halbherr. 1977. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions. Cancer Res. 37:4150.
5. Kobayashi, F., T. Nagoya, T. Koshi, and Y. Saino. 1980. Biphasic protection against bacterial infection in mice induced by vaccination of Propionibacterium acnes. Infect. Immun. 27:391.
6. Halpern, B. N., A.-R. Prévot, G. Biozzi, C. Stifel, D. Mouton, J. C. Morard, Y. Bouthillier, and C. Decreusefond. 1964. Stimulation de l'activité phagocytaire du système réticuloendothé lial provoquée par Corynebacterium parvum. RES. J. Reticuloendothel Soc. 1:77.
7. Cummins, C. S., and D. M. Linn. 1977. Reticulostimulating properties of killed vaccines of anaerobic coryneforms and other organisms. J. Natl. Cancer Inst. 59:1697.
8. Riveros-Moreno, V., and A. Niblock. 1979. Chemical properties of the principle in C. parvum that produces splenomegaly in mice. Immunology 36:495.
9. Margenthaler, J. A., K. Landeros, M. Kataoka, M. Eilers, G. Ku, and M. W. Flye. 2003. Effects of endotoxin tolerance on Propionibacterium acnes-primed lipopolysaccharide hepatic injury. J. Surg. Res. 112:102.
10. Tsuji, H., N. Mukaida, A. Harada, S. Kaneko, E. Matsushita, Y. Nakanuma, H. Tsutsui, H. Okamura, K. Nakanishi, Y. Tagawa, et al. 1999. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α, IL-12, and IL-18 production. J. Immunol. 162:1049.
11. Adlam, C., and D. E. Reid. 1977. Comparative studies on the cell wall composition of some anaerobic coryneforms of varying lympho-reticular stimulatory activity. Dev. Biol. Stand. 38:115.
12. Green, S., A. Dobrjansky, M. A. Chiasson, E. Carswell, M. K. Schwartz, and L. J. Old. 1977. Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J. Natl. Cancer Inst. 59:1519.
13. Katschinski, T., C. Galanos, A. Coumbos, and M. A. Freudenberg. 1992. γ interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect. Immun. 60:1994.
14. Freudenberg, M. A., T. Merlin, M. Gumenscheimer, C. Kalis, R. Landmann, and C. Galanos. 2001. Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection; LPS, a primary target for recognition of Gram-negative bacteria. Microbes Infect. 3:1213.
15. Freudenberg, M. A., T. Merlin, A. Sing, R. Salomao, and C. Galanos. 1999. Induction of lethality and tolerance by endotoxin are mediated by macrophages through tumor necrosis factor. In Endotoxin in Health and Disease. H. Brade, D.C. Morrrison, S. M. Opal, and S. N. Vogel, eds. Marcel Dekker, New York, pp. 719-733.
16. Galanos, C., M. Gumenscheimer, P. Muhlradt, E. Jirillo, and M. Freudenberg. 2000. MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly? J. Endotoxin Res. 6:471.
17. Merlin, T., M. Gumenscheimer, C. Galanos, and M. A. Freudenberg. 2001. TNF-α hyper-responses to Gram-negative and Gram-positive bacteria in Propionibacterium acnes primed or Salmonella typhimurium infected mice. J. Endoloxin Res. 7:157.
18. Lembo, A., C. Kalis, C. J. Kirschning, V. Mitolo, E. Jirillo, H. Wagner, C. Galanos, and M. A. Freudenberg. 2003. Differential contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella enterica serovar Typhimurium and Staphylococcus aureus in mice. Infect. Immun. 71:6058.
19. Freudenberg, M. A., Y. Kumazawa, S. Meding, J. Langhorne, and C. Galanos. 1991. γ interferon production in endotoxin-responder and -nonresponder mice during infection. Infect. Immun. 59:3484.
20. Freudenberg, M. A., and C. Galanos. 1996. Lipopolysaccharide-sensitivity of interferon-γ-receptor deficient mice. J. Endotoxin Res. 3:291.
21. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335.
22. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
23. Beutler, B., K. Hoebe, X. Du, and R. J. Ulevitch. 2003. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J. Leukocyte Biol. 74:479.
24. Kopp, E., and R. Medzhitov. 2003. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15:396.
25. Kim, J., M. T. Ochoa, S. R. Krutzik, O. Takeuchi, S. Uematsu, A. J. Legaspi, H. D. Brightbill, D. Holland, W. J. Cunliffe, S. Akira, et al. 2002. Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 169:1535.
26. Latz, E., A. Schoenemeyer, A. Visintin, K. A. Fitzgerald, B. G. Monks, C. F. Knetter, E. Lien, N. J. Nilsen, T. Espevik, and D. T. Golenbock. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5:190.
27. Sparwasser, T., L. Hultner, E. S. Koch, A. Luz, G. B. Lipford, and H. Wagner. 1999. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. J. Immunol. 162:2368.
28. Cowdery, J. S., J. H. Chace, A. K. Yi, and A. M. Krieg. 1996. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156:4570.
29. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740.
30. Galanos, C., O. Luderitz, and O. Westphal. 1979. Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal). Zentralbl. Bakteriol. 243:226.
31. Gumenscheimer, M., I. Mitov, C. Galanos, and M. A. Freudenberg. 2002. Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection. Infect. Immun. 70:5596.
32. Lohler, J., J. Gossmann, T. Kratzberg, and F. Lehmann-Grube. 1994. Murine hepatitis caused by lymphocytic choriomeningitis virus. I. The hepatic lesions. Lab. Invest. 70:263.
33. Grossman, W. J., J. T. Kimata, F. H. Wong, M. Zutter, T. J. Ley, and L. Ratner. 1995. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 92:1057.
34. Aggarwal, B. B., W. J. Kohr, P. E. Hass, B. Moffat, S. A. Spencer, W. J. Henzel, T. S. Bringman, G. E. Nedwin, D. V. Goeddel, and R. N. Harkins. 1985. Human tumor necrosis factor: production, purification, and characterization. J. Biol. Chem. 260:2345.
35. Slade, S. J., and J. Langhorne. 1989. Production of interferon-γ during infection of mice with Plasmodlum chabaudi chabaudi. Immunobiology 179:353.
36. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
37. Sing, A., T. Merlin, H. P. Knopf, P. J. Nielsen, H. Loppnow, C. Galanos, and M. A. Freudenberg. 2000. Bacterial induction of β interferon in mice is a function of the lipopolysaccharide component. Infect. Immun. 68:1600.
38. Scott, M. T., and L. Milas. 1977. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity. Cancer Res. 37:1673.
39. Pringle, A. T., C. S. Cummins, B. F. Bishop, and V. S. Viers. 1982. Fate of vaccines of Propionibacterium acnes after phagocytosis by murine macrophages. Infect. Immun. 38:371.
40. Pringle, A. T., and C. S. Cummins. 1982. Relationship between cell wall synthesis in Propionibacterium acnes and ability to stimulate the reticuloendothelial system. Infect. Immun. 35:734.
41. Kamisango, K., I. Saiki, Y. Tanio, H. Okumura, Y. Araki, I. Sekikawa, I. Azuma, and Y. Yamamura. 1982. Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes. J. Biochem. 92:23.
42. Tsuji, H., A. Harada, N. Mukaida, Y. Nakanuma, H. Bluethmann, S. Kaneko, K. Yamakawa, S. I. Nakamura, K. I. Kobayashi, and K. Matsushima. 1997. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect. Immun. 65:1892.
43. Gupta, D., Y. P. Jin, and R. Dziarski. 1995. Peptidoglycan induces transcription and secretion of TNF-α and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduction proteins in mouse macrophages. J. Immunol. 155:2620.
44. Chamaillard, M., M. Hashimoto, Y. Horie, J. Masumoto, S. Qiu, L. Saab, Y. Ogura, A. Kawasaki, K. Fukase, S. Kusumoto, et al. 2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:702.
45. Girardin, S. E., I. G. Boneca, L. A. Carneiro, A. Antignac, M. Jehanno, J. Viala, K. Tedin, M. K. Taha, A. Labigne, U. Zahringer, et al. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584.
46. Athman, R., and D. Philpott. 2004. Innate immunity via Toll-like receptors and Nod proteins. Curr. Opin. Microbiol. 7:25.
47. Gao, J. J., Q. Xue, C. J. Papasian, and D. C. Morrison. 2001. Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-α through a post-transcriptional mechanism. J. Immunol. 166:6855.
48. Krieg, A. M., L. Love-Homan, A. K. Yi, and J. T. Harty. 1998. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:2428.
49. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709.
50. Fritze, D., B. Massner, R. Becher, M. Kaufmann, H. J. Illiger, J. Hartlapp, W. Queisser, U. Abel, L. Edler, A. C. Mayr, et al. 1984. Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum. Klin. Wochenschr. 62:162.
51. Bardana, E. J., Jr. 1985. Recent developments in immunomodulatory therapy. J. Allergy Clin. Immunol. 75:423.
52. DiSaia, P. J., B. N. Bundy, S. L. Curry, J. Schlaerth, and J. T. Thigpen. 1987. Phase III study on the treatment of women with cervical cancer, stage II, IIIB, and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: a Gynecologic Oncology Group Study. Gynecol. Oncol. 26:386.
53. Burkhart, C. G., C. N. Burkhart, and P. F. Lehmann. 1999. Acne: a review of immunologic and microbiologie factors. Postgrad. Med. J. 75:328.
54. Deramo, V. A., and T. D. Ting. 2001. Treatment of Propionibacterium acnes endophthalmitis. Curr. Opin. Ophthalmol. 12:225.
55. Vandenbos, F., P. M. Roger, V. Mondain-Miton, B. Dunais, R. Fouche, P. Kreitmann, D. Carles, O. Migneco, and P. Dellamonica. 2001. Ventricular patch endocarditis caused by Propionibacterium acnes: advantages of gallium scanning. J. Infect. 43:249.
56. Sulkowski, M. S., I. Z. Abolnik, E. I. Morris, and D. L. Granger. 1994. Infectious arthritis due to Propionibacterium acnes in a prosthetic joint. Clin. Infect. Dis. 19:224.
57. Eishi, Y., M. Suga, I. Ishige, D. Kobayashi, T. Yamada, T. Takemura, T. Takizawa, M. Koike, S. Kudoh, U. Costabel, et al. 2002. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J. Clin. Microbiol. 40:198.
58. Tunney, M. M., S. Patrick, S. P. Gorman, J. R. Nixon, N. Anderson, R. I. Davis, D. Hanna, and G. Ramage. 1998. Improved detection of infection in hip replacements: a currently underestimated problem. J. Bone Joint Surg. Br. 80:568.